The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Biofilm Formation by the Emerging Fungal Pathogen Trichosporon asahii : Development, Architecture, and Antifungal Resistance
Open accessAbstract
Trichosporon asahii is the most common cause of fatal disseminated trichosporonosis, frequently associated with indwelling medical devices. Despite the use of antifungal drugs to treat trichosporonosis, infection is often persistent and is associated with high mortality. This drove our interest in evaluating the capability of T. asahii to form a biofilm on biomaterial-representative polystyrene surfaces through the development and optimization of a reproducible T. asahii -associated biofilm model. Time course analyses of viable counts and a formazan salt reduction assay, as well as microscopy studies, revealed that biofilm formation by T. asahii occurred in an organized fashion through four distinct developmental phases: initial adherence of yeast cells (0 to 2 h), germination and microcolony formation (2 to 4 h), filamentation (4 to 6 h), and proliferation and maturation (24 to 72 h). Scanning electron microscopy and confocal scanning laser microscopy revealed that mature T. asahii biofilms (72-h) displayed a complex, heterogeneous three-dimensional structure, consisting of a dense network of metabolically active yeast cells and hyphal elements completely embedded within exopolymeric material. Antifungal susceptibility testing demonstrated a remarkable rise in the MICs of sessile T. asahii cells against clinically used amphotericin B, caspofungin, voriconazole, and fluconazole compared to their planktonic counterparts. In particular, T. asahii biofilms were up to 16,000 times more resistant to voriconazole, the most active agent against planktonic cells (MIC, 0.06 μg/ml). Our results suggest that the ability of T. asahii to form a biofilm may be a major factor in determining persistence of the infection in spite of in vitro susceptibility of clinical isolates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Cited by
Critical review on biofilm methods
Azeredo, J., Azevedo, N. F., Briandet, R., Cerca, N., Coenye, T., Costa, A. R., Desvaux, M., Di Bonaventura, G., Hébraud, M., Jaglic, Z., et al. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2016.1208146 · Cited by 1,045
Self-citationEpidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Essential Oils and Antifungal Activity
Nazzaro, F., Fratianni, F., Coppola, R., & Feo, V. D. (2017) · Pharmaceuticals · doi:10.3390/ph10040086 · Cited by 817
Tariq, S., Wani, S., Rasool, W., Shafi, K., Bhat, M. A., Prabhakar, A., Shalla, A. H., & Rather, M. A. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103580 · Cited by 693
Resistance to Antifungal Agents: Mechanisms and Clinical Impact
Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
“Different Trichosporon species can cause disseminated life-threatening infections associated with biofilm-related infections [14, 19, 20], including cardiac grafts [21], catheters [22], and breast implants [23].”
BackgroundCurrent Knowledge of Trichosporon spp. and Trichosporonosis
Colombo, A. L., Padovan, A. C. B., & Chaves, G. M. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00003-11 · Cited by 545
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2012) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 505
Our Current Understanding of Fungal Biofilms
Ramage, G., Mowat, E., Jones, B., Williams, C., & Lopez-Ribot, J. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903241436 · Cited by 483
Fanning, S., & Mitchell, A. P. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002585 · Cited by 465
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
Scorzoni, L., de Paula e Silva, A. C. A., Marcos, C. M., Assato, P. A., de Melo, W. C. M. A., de Oliveira, H. C., Costa-Orlandi, C. B., Mendes-Giannini, M. J. S., & Fusco-Almeida, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00036 · Cited by 418
Fungal Biofilms, Drug Resistance, and Recurrent Infection
Desai, J. V., Mitchell, A. P., & Andes, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019729 · Cited by 252
“These examples illustrate the principle that biofilm growth can provide a useful model for infection even if a canonical abiotic-surface biofilm is not clearly associated with infection.”
BackgroundKalan, L., Loesche, M., Hodkinson, B. P., Heilmann, K., Ruthel, G., Gardner, S. E., & Grice, E. A. (2016) · mBio · doi:10.1128/mbio.01058-16 · Cited by 246
Microscopy Methods for Biofilm Imaging: Focus on SEM and VP-SEM Pros and Cons
Relucenti, M., Familiari, G., Donfrancesco, O., Taurino, M., Li, X., Chen, R., Artini, M., Papa, R., & Selan, L. (2021) · Biology · doi:10.3390/biology10010051 · Cited by 228
Biofilm Formation by Pneumocystis spp
Cushion, M. T., Collins, M. S., & Linke, M. J. (2009) · Eukaryotic Cell · doi:10.1128/ec.00202-08 · Cited by 96
Candida Species: New Insights into Biofilm Formation
Cuéllar-Cruz, M., López-Romero, E., Villagómez-Castro, J. C., & Ruiz-Baca, E. (2012) · Future Microbiology · doi:10.2217/fmb.12.48 · Cited by 80
Keratitis-Associated Fungi Form Biofilms with Reduced Antifungal Drug Susceptibility
Zhang, X., Sun, X., Wang, Z., Zhang, Y., & Hou, W. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10810 · Cited by 49
Susceptibility of Pneumocystis to Echinocandins in Suspension and Biofilm Cultures
Cushion, M. T., & Collins, M. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00017-11 · Cited by 38
“Many drugs have reduced efficacy against fungi within biofilms (1, 13, 21, 29, 31), and microbes within biofilms are less susceptible to host immune responses (20).”
BackgroundTrichosporon asahii and Trichosporon inkin biofilms produce antifungal-tolerant persister cells
Cordeiro, R. D. A., Aguiar, A. L. R., da Silva, B. N., Pereira, L. M. G., Portela, F. V. M., de Camargo, Z. P., de Lima-Neto, R. G., Castelo-Branco, D. D. S. C. M., Rocha, M. F. G., & Sidrim, J. J. C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.645812 · Cited by 34
Metadata
- Authors
- Di Bonaventura, G., Pompilio, A., Picciani, C., Iezzi, M., D'Antonio, D., & Piccolomini, R.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2006-10
- Volume
- 50
- Issue
- 10
- Pages
- 3269-3276
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2050809614
- Cited by
- 226
- References
- 1
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.